Subscribe to eTOC

Rimegepant Is Effective for Acute Migraine Pain at 2 Hours

Neurology Today At the American Headache Society Annual Meeting: Migraine patients treated with rimegepant, a CGRP receptor antagonist, were free from pain and free from their most bothersome symptom two hours after the dose compared with placebo.

Read the full report with Neurology Today At the Meetings: http://bit.ly/NT-AHS-vasoconstrictive


Recent Videos